CVS Health ROE 2010-2024 | CVS
Current and historical return on equity (ROE) values for CVS Health (CVS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CVS Health ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-09-30 |
$5.02B |
$75.11B |
6.67% |
| 2024-06-30 |
$7.19B |
$75.11B |
9.57% |
| 2024-03-31 |
$7.32B |
$74.15B |
9.82% |
| 2023-12-31 |
$8.34B |
$76.64B |
11.29% |
| 2023-09-30 |
$8.63B |
$74.51B |
11.87% |
| 2023-06-30 |
$2.97B |
$73.00B |
4.13% |
| 2023-03-31 |
$4.09B |
$71.58B |
5.65% |
| 2022-12-31 |
$4.31B |
$71.77B |
5.90% |
| 2022-09-30 |
$3.37B |
$71.01B |
4.56% |
| 2022-06-30 |
$8.38B |
$75.51B |
11.18% |
| 2022-03-31 |
$8.13B |
$74.14B |
10.93% |
| 2021-12-31 |
$8.00B |
$75.38B |
10.86% |
| 2021-09-30 |
$7.58B |
$74.62B |
10.49% |
| 2021-06-30 |
$7.20B |
$73.57B |
10.16% |
| 2021-03-31 |
$7.40B |
$71.16B |
10.63% |
| 2020-12-31 |
$7.18B |
$69.70B |
10.53% |
| 2020-09-30 |
$7.95B |
$69.11B |
11.91% |
| 2020-06-30 |
$8.26B |
$68.36B |
12.66% |
| 2020-03-31 |
$7.22B |
$65.47B |
11.36% |
| 2019-12-31 |
$6.63B |
$64.17B |
10.67% |
| 2019-09-30 |
$4.47B |
$62.93B |
7.35% |
| 2019-06-30 |
$4.33B |
$61.60B |
7.99% |
| 2019-03-31 |
$-0.17B |
$60.01B |
-0.36% |
| 2018-12-31 |
$-0.59B |
$58.54B |
-1.40% |
| 2018-09-30 |
$3.11B |
$36.62B |
8.38% |
| 2018-06-30 |
$3.01B |
$35.61B |
8.19% |
| 2018-03-31 |
$6.67B |
$38.68B |
18.35% |
| 2017-12-31 |
$6.62B |
$37.70B |
18.85% |
| 2017-09-30 |
$5.04B |
$34.87B |
14.44% |
| 2017-06-30 |
$5.30B |
$34.15B |
15.05% |
| 2017-03-31 |
$5.12B |
$33.84B |
14.49% |
| 2016-12-31 |
$5.32B |
$36.83B |
14.81% |
| 2016-09-30 |
$5.11B |
$35.95B |
14.19% |
| 2016-06-30 |
$4.81B |
$34.77B |
13.26% |
| 2016-03-31 |
$5.16B |
$36.03B |
13.99% |
| 2015-12-31 |
$5.24B |
$37.20B |
14.11% |
| 2015-09-30 |
$5.06B |
$37.18B |
13.56% |
| 2015-06-30 |
$4.76B |
$37.13B |
12.68% |
| 2015-03-31 |
$4.74B |
$37.00B |
12.53% |
| 2014-12-31 |
$4.64B |
$37.96B |
12.19% |
| 2014-09-30 |
$4.59B |
$38.11B |
12.04% |
| 2014-06-30 |
$4.89B |
$38.13B |
12.80% |
| 2014-03-31 |
$4.77B |
$38.21B |
12.41% |
| 2013-12-31 |
$4.59B |
$37.94B |
11.96% |
| 2013-09-30 |
$4.44B |
$38.53B |
11.59% |
| 2013-06-30 |
$4.20B |
$38.91B |
11.08% |
| 2013-03-31 |
$4.04B |
$38.21B |
10.73% |
| 2012-12-31 |
$3.86B |
$37.65B |
10.27% |
| 2012-09-30 |
$3.81B |
$36.92B |
10.11% |
| 2012-06-30 |
$3.68B |
$37.91B |
9.70% |
| 2012-03-31 |
$3.53B |
$38.05B |
9.29% |
| 2011-12-31 |
$3.46B |
$38.05B |
9.13% |
| 2011-09-30 |
$3.42B |
$37.49B |
9.05% |
| 2011-06-30 |
$3.36B |
$38.24B |
8.94% |
| 2011-03-31 |
$3.37B |
$37.92B |
9.10% |
| 2010-12-31 |
$3.43B |
$37.70B |
9.40% |
| 2010-09-30 |
$3.45B |
$36.64B |
9.59% |
| 2010-06-30 |
$3.66B |
$35.87B |
10.25% |
| 2010-03-31 |
$3.73B |
$35.69B |
10.41% |
| 2009-12-31 |
$3.70B |
$35.77B |
10.35% |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$73.000B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
